Tactile Systems Technology Stock

Tactile Systems Technology Debt/EBITDA

The Total Debt to EBITDA Ratio of Tactile Systems Technology (TCMD) as of Aug 19, 2026 is -2.77. In the previous year, Total Debt to EBITDA Ratio was 1.06 — a change of -361.25% (lower).

Debt/EBITDA

-2.77

YoY

-361.25%

Last updated:

Total Debt to EBITDA Ratio of Tactile Systems Technology is 2026 -2.77 . Total Debt to EBITDA Ratio of Tactile Systems Technology was 2025 1.06 . It decreases by -361.25% lower compared to the previous year.
Access this data via the Eulerpool API

Tactile Systems Technology Stock analysis

What does Tactile Systems Technology do? Tactile Systems Technology Inc. is an American medical technology company that produces innovative therapy devices for the treatment of peripheral arterial disease (PAD) and lymphatic diseases. The company was founded in 1995 by Gerald R. Mattys and is headquartered in Minneapolis, Minnesota. Tactile Systems Technology is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Tactile Systems Technology stock

Total Debt to EBITDA Ratio of Tactile Systems Technology is -2.77 in 2026.

Total Debt to EBITDA Ratio of Tactile Systems Technology changed from 1.06 to -2.77, representing a -361.25% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Debt to EBITDA Ratio Tactile Systems Technology since 2006 – with annual values, charts, and detailed analysis.

Debt/EBITDA measures total debt relative to earnings before interest, taxes, depreciation, and amortization. It indicates the years needed to repay all debt from EBITDA.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Total Debt to EBITDA Ratio's Tactile Systems Technology with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — Tactile Systems Technology

All Key Metrics — Tactile Systems Technology